Perspectives Archives - Page 4 of 5

Biotech companies can also fail

Nowadays, biotech headlines usually talk about hundred million series A financings, oversubscribed IPOs, or multi-billion exits. But success is not guaranteed at all, even when…

clement18.03.2021

Female scientist looking through microscope

Perspectives

Driving value from genomics in life sciences

In this paper, "Driving value from genomics in life sciences: rising to the data challenge", KPMG explores the cornerstone for genomic data leadership: a robust…

clement18.03.2021

Perspectives

Q&A: Market access strategies for innovative drugs

European health systems are under pressure because of the aging population, the increasing amount of chronic diseases and a rise of healthcare costs caused by…

clement08.12.2020

Business people shaking hands in agreement

Perspectives

“No Innovation Without Cooperation”

Leonildo Delgado, Manager Innovation & Sourcing for BaseLaunch, contributed to this article on How Switzerland Innovation Promotes Cooperation Between Industry, Research and Startups. In this article,…

clement19.11.2020

Perspectives

5 events that shaped the biotechnology industry and bioscience research

In the course of just under two months that started 40 years ago the week of Oct. 20, five events occurred that shaped the biotechnology…

clement19.10.2020

Perspectives

Featured Interview: BaseLaunch Q&A session with Dr. Philipp Marchand

“IP rights are usually the true asset that a start-up company has.” Dr. Philipp Marchand talks with BaseLaunch and takes some questions from an audience…

clement28.07.2020

Perspectives

Basic biotech starter kit: a flourishing ecosystem and highly focused support

“Go start a biotech company in a strong biotech ecosystem” is our conclusion from this Nature paper, which tracks down every biotech start-up emerging (between…

clement08.05.2020

Perspectives

Featured Interview: Baselaunch chats with Silvio Bonaccio, ETH Zurich

Silvio Bonaccio is delighted by the strong entrepreneurial spirit that he encounters in his work as Head of ETH transfer. It took time, effort and…

clement08.05.2020

Perspectives

KPMG: Reshaping the future of pharma

From our partner, KPGM: The rules of engagement in the global pharmaceutical industry are changing rapidly with disruption in this industry already well underway. Two…

clement06.12.2019

Perspectives

“The first steps are slow and then suddenly things start rolling”

After more than 25 years in the pharma business, Andreas Katopodis founded the biotech company Anaveon together with Professor Onur Boyman. In 2019, the startup…

clement06.12.2019

Perspectives

Biotech companies can also fail

Driving value from genomics in life sciences

Q&A: Market access strategies for innovative drugs

“No Innovation Without Cooperation”

5 events that shaped the biotechnology industry and bioscience research

Featured Interview: BaseLaunch Q&A session with Dr. Philipp Marchand

Basic biotech starter kit: a flourishing ecosystem and highly focused support

Featured Interview: Baselaunch chats with Silvio Bonaccio, ETH Zurich

KPMG: Reshaping the future of pharma

“The first steps are slow and then suddenly things start rolling”

Useful links

Contact us

Sign up for our newsletter and event invitations

Follow us